Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "015591-2022",
"tag": [
"tender"
],
"date": "2022-06-07T10:35:06+01:00",
"ocid": "ocds-h6vhtk-03438d",
"buyer": {
"id": "GB-FTS-4546",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000695663"
}
],
"tender": {
"id": "ocds-h6vhtk-03438d",
"lots": [
{
"id": "1",
"value": {
"amount": 4300000,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of thirty-six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "The Supply of Lenalidomide capsules to NHS Scotland with the full range of presentation with Indications as the originator product.\nThe Authority intends awarding as an unranked multi supplier framework on a line by line basis.\nFull details of Goods and volumes can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "PPP",
"type": "quality",
"description": "15"
},
{
"type": "price",
"description": "85"
}
]
},
"contractPeriod": {
"durationInDays": 360
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP39722f Lenalidomide",
"value": {
"amount": 4300000,
"currency": "GBP"
},
"status": "active",
"coveredBy": [
"GPA"
],
"bidOpening": {
"date": "2022-07-08T12:00:00+01:00"
},
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"techniques": {
"frameworkAgreement": {
"maximumParticipants": null
},
"hasFrameworkAgreement": true
},
"awardPeriod": {
"startDate": "2022-07-08T12:00:00+01:00"
},
"description": "This Framework Agreement is for the supply of Lenalidomide to health boards across NHS Scotland. Full details is contained in section II.2 of this notice.",
"tenderPeriod": {
"endDate": "2022-07-08T12:00:00+01:00"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"hasRecurrence": false,
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"submissionMethod": [
"electronicSubmission"
],
"procurementMethod": "open",
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"appliesTo": [
"supplier"
],
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"minimum": "a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.\n(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.\n(c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products.\n(d) Confirmation that all tendered Goods must come with a MHRA approved Pregnancy Prevention Plan (PPP). This can be in the form of paper or electronic.",
"appliesTo": [
"supplier"
],
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.\n(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.\n(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.\n(d) All tendered Goods must come with a MHRA approved Pregnancy Prevention Plan (PPP). This can be in the form of paper or electronic."
}
]
},
"mainProcurementCategory": "goods",
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-4546",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"details": {
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/",
"buyerProfile": "http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"contactPoint": {
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"name": "Ruaridh Armitage",
"email": "ruaridh.armitage@nhs.scot",
"telephone": "+44 1698794410"
}
},
{
"id": "GB-FTS-809",
"name": "Edinburgh Sheriff Court",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "Sheriff Court House, 27 Chambers Street"
},
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
},
"identifier": {
"legalName": "Edinburgh Sheriff Court"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
}
}
],
"language": "en",
"description": "The estimated value referred to in Section II.I.5 cover the twelve (12) months framework duration.\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 21440. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nThe Contracting Authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason: The PPP will be an IT programme and is not expected to provide any community benefits.\nIt is envisaged that sub-contractors might be utilised in delivery of this framework agreement. A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nIt is a mandatory requirement that potential framework participants agree to support the concept, provision and ongoing development of community benefits provision in relation to this framework.\nPotential framework participants are required to agree to this mandatory requirement. They are also requested to provide a brief summary of the community benefits that have recently been delivered within Scotland, if at all, and also what impact and outcomes these have achieved.\nPotential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this contract if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.\nFor further information please visit NHSS Community Benefit Gateway\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 21440. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nThe Statement of Requirement will detail the Community Benefit background and objectives. The contract will mandate that suppliers respond in its tender outlining current Community Benefit proposals if successful and mandating that they support the overall Community Benefit concept and process including a contract and supplier management process post award.\n(SC Ref:695663)",
"initiationType": "tender"
}Complete JSON history (1 releases)
7 Jun 2022 · 015591-2022 · tender
{
"id": "015591-2022",
"tag": [
"tender"
],
"date": "2022-06-07T10:35:06+01:00",
"ocid": "ocds-h6vhtk-03438d",
"buyer": {
"id": "GB-FTS-4546",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000695663"
}
],
"tender": {
"id": "ocds-h6vhtk-03438d",
"lots": [
{
"id": "1",
"value": {
"amount": 4300000,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of thirty-six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "The Supply of Lenalidomide capsules to NHS Scotland with the full range of presentation with Indications as the originator product.\nThe Authority intends awarding as an unranked multi supplier framework on a line by line basis.\nFull details of Goods and volumes can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "PPP",
"type": "quality",
"description": "15"
},
{
"type": "price",
"description": "85"
}
]
},
"contractPeriod": {
"durationInDays": 360
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP39722f Lenalidomide",
"value": {
"amount": 4300000,
"currency": "GBP"
},
"status": "active",
"coveredBy": [
"GPA"
],
"bidOpening": {
"date": "2022-07-08T12:00:00+01:00"
},
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"techniques": {
"frameworkAgreement": {
"maximumParticipants": null
},
"hasFrameworkAgreement": true
},
"awardPeriod": {
"startDate": "2022-07-08T12:00:00+01:00"
},
"description": "This Framework Agreement is for the supply of Lenalidomide to health boards across NHS Scotland. Full details is contained in section II.2 of this notice.",
"tenderPeriod": {
"endDate": "2022-07-08T12:00:00+01:00"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"hasRecurrence": false,
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"submissionMethod": [
"electronicSubmission"
],
"procurementMethod": "open",
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"appliesTo": [
"supplier"
],
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"minimum": "a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.\n(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.\n(c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products.\n(d) Confirmation that all tendered Goods must come with a MHRA approved Pregnancy Prevention Plan (PPP). This can be in the form of paper or electronic.",
"appliesTo": [
"supplier"
],
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.\n(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.\n(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.\n(d) All tendered Goods must come with a MHRA approved Pregnancy Prevention Plan (PPP). This can be in the form of paper or electronic."
}
]
},
"mainProcurementCategory": "goods",
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-4546",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"details": {
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/",
"buyerProfile": "http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"contactPoint": {
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"name": "Ruaridh Armitage",
"email": "ruaridh.armitage@nhs.scot",
"telephone": "+44 1698794410"
}
},
{
"id": "GB-FTS-809",
"name": "Edinburgh Sheriff Court",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "Sheriff Court House, 27 Chambers Street"
},
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
},
"identifier": {
"legalName": "Edinburgh Sheriff Court"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
}
}
],
"language": "en",
"description": "The estimated value referred to in Section II.I.5 cover the twelve (12) months framework duration.\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 21440. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nThe Contracting Authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason: The PPP will be an IT programme and is not expected to provide any community benefits.\nIt is envisaged that sub-contractors might be utilised in delivery of this framework agreement. A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nIt is a mandatory requirement that potential framework participants agree to support the concept, provision and ongoing development of community benefits provision in relation to this framework.\nPotential framework participants are required to agree to this mandatory requirement. They are also requested to provide a brief summary of the community benefits that have recently been delivered within Scotland, if at all, and also what impact and outcomes these have achieved.\nPotential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this contract if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.\nFor further information please visit NHSS Community Benefit Gateway\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 21440. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nThe Statement of Requirement will detail the Community Benefit background and objectives. The contract will mandate that suppliers respond in its tender outlining current Community Benefit proposals if successful and mandating that they support the overall Community Benefit concept and process including a contract and supplier management process post award.\n(SC Ref:695663)",
"initiationType": "tender"
}